, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas. Roussel M, Lhomme F, Roe CE, Bartkowiak T, Gravelle P, Laurent C, Fest T, Irish JM (2020) Cancer Immunol Immunother 69(3): 407-420
    › Primary publication · 31919622 (PubMed)
  2. Picturing Polarized Myeloid Phagocytes and Regulatory Cells by Mass Cytometry. Roussel M, Bartkowiak T, Irish JM (2019) Methods Mol Biol : 217-226
    › Primary publication · 31077108 (PubMed) · PMC6886519 (PubMed Central)
  3. Machine learning reveals chronic graft--host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies. Gandelman JS, Byrne MT, Mistry AM, Polikowsky HG, Diggins KE, Chen H, Lee SJ, Arora M, Cutler C, Flowers M, Pidala J, Irish JM, Jagasia MH (2019) Haematologica 104(1): 189-196
    › Primary publication · 30237265 (PubMed) · PMC6312024 (PubMed Central)
  4. Location-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesis. Rushing GV, Brockman AA, Bollig MK, Leelatian N, Mobley BC, Irish JM, Ess KC, Fu C, Ihrie RA (2019) Life Sci Alliance 2(2)
    › Primary publication · 30910807 (PubMed) · PMC6435042 (PubMed Central)
  5. Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response. Huse K, Wogsland CE, Polikowsky HG, Diggins KE, Smeland EB, Myklebust JH, Irish JM (2019) Cytometry A 95(4): 442-449
    › Primary publication · 30838773 (PubMed) · PMC6711772 (PubMed Central)
  6. Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types. Greenplate AR, McClanahan DD, Oberholtzer BK, Doxie DB, Roe CE, Diggins KE, Leelatian N, Rasmussen ML, Kelley MC, Gama V, Siska PJ, Rathmell JC, Ferrell PB, Johnson DB, Irish JM (2019) Cancer Immunol Res 7(1): 86-99
    › Primary publication · 30413431 (PubMed) · PMC6318034 (PubMed Central)
  7. Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors. Mistry AM, Greenplate AR, Ihrie RA, Irish JM (2019) FEBS J 286(8): 1523-1539
    › Primary publication · 30549207 (PubMed) · PMC6478512 (PubMed Central)
  8. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling. Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2018) Clin Cancer Res 24(4): 870-881
    › Primary publication · 29217528 (PubMed) · PMC5815910 (PubMed Central)
  9. Genomic Profiling of T-Cell Neoplasms Reveals Frequent and Mutations With Clonal Evasion From Targeted Therapies. Greenplate A, Wang K, Tripathi RM, Palma N, Ali SM, Stephens PJ, Miller VA, Shyr Y, Guo Y, Reddy NM, Kozhaya L, Unutmaz D, Chen X, Irish JM, Davé UP (2018) JCO Precis Oncol
    › Primary publication · 30079384 (PubMed) · PMC6072266 (PubMed Central)
  10. Generating Quantitative Cell Identity Labels with Marker Enrichment Modeling (MEM). Diggins KE, Gandelman JS, Roe CE, Irish JM (2018) Curr Protoc Cytom : 10.21.1-10.21.28
    › Primary publication · 29345329 (PubMed) · PMC5774653 (PubMed Central)